Differences in Sex-Specific Frequency of Glucocerebrosidase Variant Carriers and Familial Parkinsonism
- PMID: 36054306
- PMCID: PMC9669136
- DOI: 10.1002/mds.29197
Differences in Sex-Specific Frequency of Glucocerebrosidase Variant Carriers and Familial Parkinsonism
Abstract
Background: Although men and women with the LRRK2 G2019S variant appear to be equally likely to have Parkinson's disease (PD), the sex-distribution among glucocerebrosidase (GBA) variant carriers with PD, including limited to specific variant severities of GBA, is not well understood. Further, the sex-specific genetic contribution to PD without a known genetic variant is controversial.
Objectives: To better understand sex differences in genetic contribution to PD, especially sex-specific frequencies among GBA variant carriers with PD (GBA PD) and LRRK2-G2019S variant carriers with PD (LRRK2 PD).
Methods: We assess differences in the sex-specific frequency in GBA PD, including in subsets of GBA variant severity, LRRK2 PD, and idiopathic PD in an Ashkenazi Jewish cohort with PD. Further, we expand prior work evaluating differences in family history of parkinsonism.
Results: Both idiopathic PD (267/420 men, 63.6%) (P < 0.001) and GBA PD overall (64/107, 59.8%) (P = 0.042) were more likely to be men, whereas no difference was seen in LRRK2 PD (50/99, 50.5%) and LRRK2/GBA PD (5/10, 50%). However, among GBA PD probands, severe variant carriers were more likely to be women (15/19 women, 79.0%) (P = 0.005), whereas mild variant carriers (44/70 men, 62.9%) (P = 0.039) and risk-variant carriers (15/17 men, 88.2%) (P = 0.001) were more likely to be men.
Conclusions: Our study demonstrates that the male-sex predominance present in GBA PD overall was not consistent across GBA variant severities, and a female-sex predominance was present among severe GBA variant carriers. Therefore, research and trial designs for PD should consider sex-specific differences, including across GBA variant severities. © 2022 International Parkinson and Movement Disorder Society.
Keywords: GBA; LRRK2; Parkinson's; family history; sex.
© 2022 International Parkinson and Movement Disorder Society.
Conflict of interest statement
Conflict of interest statement: None of the authors reports any conflict of interest.
Figures


Comment in
-
Reply to: "Differences in Sex-Specific Frequency of Glucocerebrosidase Variant Carriers and Familial Parkinsonism".Mov Disord. 2023 Apr;38(4):712-713. doi: 10.1002/mds.29351. Mov Disord. 2023. PMID: 37061878 No abstract available.
-
Differences in Sex-Specific Frequency of Glucocerebrosidase Variant Carriers and Familial Parkinsonism.Mov Disord. 2023 Apr;38(4):714-715. doi: 10.1002/mds.29353. Mov Disord. 2023. PMID: 37061880 Free PMC article. No abstract available.
-
Differences in Sex-Specific Frequency of Glucocerebrosidase Variant Carriers and Familial Parkinsonism.Mov Disord. 2023 Apr;38(4):713-714. doi: 10.1002/mds.29348. Mov Disord. 2023. PMID: 37061884 No abstract available.
Similar articles
-
Carriers of both GBA and LRRK2 mutations, compared to carriers of either, in Parkinson's disease: Risk estimates and genotype-phenotype correlations.Parkinsonism Relat Disord. 2019 May;62:179-184. doi: 10.1016/j.parkreldis.2018.12.014. Epub 2018 Dec 13. Parkinsonism Relat Disord. 2019. PMID: 30573413
-
Age at Onset of Parkinson's Disease Among Ashkenazi Jewish Patients: Contribution of Environmental Factors, LRRK2 p.G2019S and GBA p.N370S Mutations.J Parkinsons Dis. 2020;10(3):1123-1132. doi: 10.3233/JPD-191829. J Parkinsons Dis. 2020. PMID: 32310186
-
Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.Brain. 2015 Sep;138(Pt 9):2648-58. doi: 10.1093/brain/awv179. Epub 2015 Jun 27. Brain. 2015. PMID: 26117366 Free PMC article.
-
LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease.Transl Neurodegener. 2022 Jan 31;11(1):5. doi: 10.1186/s40035-022-00281-6. Transl Neurodegener. 2022. PMID: 35101134 Free PMC article. Review.
-
Precision medicine in Parkinson's disease patients with LRRK2 and GBA risk variants - Let's get even more personal.Transl Neurodegener. 2020 Oct 16;9(1):39. doi: 10.1186/s40035-020-00218-x. Transl Neurodegener. 2020. PMID: 33066808 Free PMC article. Review.
Cited by
-
Differences in Sex-Specific Frequency of Glucocerebrosidase Variant Carriers and Familial Parkinsonism.Mov Disord. 2023 Apr;38(4):714-715. doi: 10.1002/mds.29353. Mov Disord. 2023. PMID: 37061880 Free PMC article. No abstract available.
-
Consensus Guidance for Genetic Counseling in GBA1 Variants: A Focus on Parkinson's Disease.Mov Disord. 2024 Dec;39(12):2144-2154. doi: 10.1002/mds.30006. Epub 2024 Sep 11. Mov Disord. 2024. PMID: 39258449 Free PMC article. Review.
-
The Molecular Impact of Glucosylceramidase Beta 1 (Gba1) in Parkinson's Disease: a New Genetic State of the Art.Mol Neurobiol. 2024 Sep;61(9):6754-6770. doi: 10.1007/s12035-024-04008-8. Epub 2024 Feb 13. Mol Neurobiol. 2024. PMID: 38347286 Review.
-
Sex Differences in Parkinson's Disease: A Narrative Review.Neurol Ther. 2025 Feb;14(1):57-70. doi: 10.1007/s40120-024-00687-6. Epub 2024 Dec 4. Neurol Ther. 2025. PMID: 39630386 Free PMC article. Review.
-
Male sex accelerates cognitive decline in GBA1 Parkinson's disease.NPJ Parkinsons Dis. 2025 Mar 4;11(1):41. doi: 10.1038/s41531-025-00883-7. NPJ Parkinsons Dis. 2025. PMID: 40038314 Free PMC article.
References
-
- De Lau LML, Giesbergen PCLM, De Rijk MC, Hofman A, Koudstaal PJ, Breteler MMB. Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study. Neurology. 2004;63(7):1240–1244. doi:10.1212/01.WNL.0000140706.52798.BE - DOI - PubMed
-
- Ray Dorsey E, Elbaz A, Nichols E, et al. Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(11):939–953. doi:10.1016/S1474-4422(18)30295-3/ATTACHMENT/30B76483-5DB3-41F7-993B-E817505F2129/MMC1.PDF - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical